We are live on ! Find out more
VNRX icon

VolitionRx Ltd

24 hedge funds and large institutions have $5.89M invested in VolitionRx Ltd in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more capital invested

Capital invested by funds: $4.56M → $5.89M (+$1.33M)

0.07% more ownership

Funds ownership: 0.4%0.47% (+0.07%)

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

14% less funds holding

Funds holding: 2824 (-4)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
24
Holders Change
-4
Holders Change %
-14.29%
% of All Funds
0.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
7
Reduced
7
Closed
6
Calls
$31K
Puts
Net Calls
+$31K
Net Calls Change
+$4K

VNRX Hedge Fund Activity: Q1 2024 in Review

24 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2024, worth a combined $5.89M — up 29% from $4.56M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of VNRX and 2 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 7 added.

The largest buyer was Lagoda Investment Management, adding an estimated $1.32M. The largest seller was Virtu Financial, exiting entirely with an estimated $19K sold.

  • 24 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2024, down from 28 in Q4 2023.
  • Funds reported $5.89M of VolitionRx Ltd stock for Q1 2024, up 29% quarter-over-quarter.
  • 2 funds opened new VolitionRx Ltd positions in Q1 2024 and 6 closed out, a net change of -4 holders.
  • The largest VolitionRx Ltd buyer in Q1 2024 was Lagoda Investment Management, an estimated $1.32M added.
  • The largest VolitionRx Ltd seller in Q1 2024 was Virtu Financial, an estimated $19K sold.

Based on aggregated 13F filings for Q1 2024.